Cargando…
A COMPARISON OF PULSE METHYLPREDNISOLONE TO LOW-DOSE METHYLPREDNISOLONE IN CRITICALLY-ILL PATIENTS WITH SARS-COV-2 PNEUMONIA: RETROSPECTIVE, OBSERVATIONAL STUDY
INTRO: The RECOVERY trial showed evidence that dexamethasone given at moderate doses for a short period of time reduced mortality in comparison to standard of care in hospitalised COVID-19 patients. However, there is no evidence to demonstrate whether higher doses of steroid may improve or worsen th...
Autores principales: | Bidin, F.N., Chow, T.S., Wong, P.S., Leong, K.N., Lim, C.H., Looi, C.L., Chin, J.Z., Chuah, C.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186876/ http://dx.doi.org/10.1016/j.ijid.2023.04.312 |
Ejemplares similares
-
PULSED METHYLPREDNISOLONE USAGE IN ARDS DUE TO VIRAL PNEUMONIA
por: Szeto, C.H.
Publicado: (2019) -
PRELIMINARY ANALYSIS ON EFFICACY OF RITONAVIR-BOOSTED NIRMATRELVIR ON DISEASE PROGRESSION AMONG HIGH-RISK HOSPITALISED COVID-19 PATIENTS: A RETROSPECTIVE CASE-CONTROL STUDY
por: Lee, S.P., et al.
Publicado: (2023) -
Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children
por: Tamura, Akihiro, et al.
Publicado: (2008) -
Is the treatment with pulses of methylprednisolone safe?
por: Bednarczuk, Tomasz, et al.
Publicado: (2013) -
Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children
por: You, Sun Young, et al.
Publicado: (2014)